Untreated patients with multiple sclerosis: A study of French expert centers.
Xavier MoissetAudrey-Anne FouchardBruno PereiraFrédéric TaitheGuillaume MatheyGilles EdanJonathan CironBruno BrochetJérôme De SèzeCaroline PapeixPatrick VermerschPierre LabaugeGilles DeferChristine Lebrun-FrenayThibault MoreauDavid LaplaudEric BergerJean PelletierBruno StankoffOlivier GoutEric ThouvenotOlivier HeinzlefAbdullatif Al-KhedrBertrand BourreOlivier CasezPhilippe CabreAlexis MontcuquetAlain CréangeJean-Philippe CamdessanchéSerge BakchineAude MauroussetKarolina HankiewiczCorinne PottierNicolas MaubeugeDalia Dimitri BoulosChantal NifleSandra VukusicPierre Clavelounull nullPublished in: European journal of neurology (2021)
A significant proportion of patients with MS did not receive any DMT, even though such treatments are reimbursed by the healthcare system for French patients. This result highlights the unmet need for current DMTs for a large subgroup of patients with MS.